Benefit of Scarf Support on Skin-to-skin Time and Portage in Neonatology and at Home
NCT ID: NCT04034719
Last Updated: 2022-08-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
80 participants
INTERVENTIONAL
2019-10-08
2022-03-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In University hospital of Saint-Etienne, the developmental care program has been developed since 2002 in all neonatology units and advocates the practice of skin-to-skin carrying between the parent (father or mother) and his baby, from the time of the hospitalization. Professionals in units who have long been thinking about the concept of attachment and the benefits of skin-to-skin, wish to validate the use of the wearing scarf as a tool for the practice of skin -in-skin in neonatology then back home by performing a randomized monocentric prospective longitudinal study.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of a Scarf to Facilitate Mother-newborn Contact Designed to Facilitate Skin-to-skin Contact
NCT04881071
Hypothermia Prevention in Low Birthweight and Preterm Infants
NCT04364204
Carrier Care: An Innovative Approach to Support Small Babies in the NICU
NCT07142564
Kangaroo Mother Care With Plastic Bag (Trials 2A & 2B)
NCT03141723
Is Skin-to-Skin Care Helpful for Preterm Infants and Their Mothers After Birth?
NCT00917085
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group
Newborn hospitalized in the neonatal department with their parent will be included.
They will have a portage scarf to help them to keep their child skin-to-skin
portage scarf
Parents will be carried their newborn with the portage scarf provided by the department.
Control group
Newborn hospitalized in the neonatal department with their parent will be included.
They wont have a portage scarf.
usual practice
Parents will be carried their newborn as their usual practice.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
portage scarf
Parents will be carried their newborn with the portage scarf provided by the department.
usual practice
Parents will be carried their newborn as their usual practice.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Any newborn regardless of gestational age and postnatal age hospitalized in the neonatology department of the University Hospital of Saint-Etienne
For the parent (father or mother):
* Be a parent of a child eligible for the research protocol
Exclusion Criteria
* Need for sedation or analgesia for the duration of the study
* Orthopedic pathology incompatible with the practice of carrying
* Other medical contraindications to carriage
* Absence of parents
For the parent (father or mother):
* Family, social or psychological situation compromising the evaluation
* No fluency in the French language
10 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Saint Etienne
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hugues PATURAL, MD PhD
Role: PRINCIPAL_INVESTIGATOR
CHU SAINT-ETIENNE
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Saint-Etienne
Saint-Etienne, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019-A01113-54
Identifier Type: OTHER
Identifier Source: secondary_id
19CH089
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.